Study On Development Strategy And Implementation Of KM Biotechnology Co. Ltd

With the arrival of the inevitable global economic integration and the rapid development of the biotechnology industry, the government gives more attention to biological industry and medical reforms, And for the reason that increase of disposable income and accelerate of the gradual aging of the population, enterprises of in vitro diagnostic reagents are facing not only greater challenges but also attractive opportunities. It is an important issue for how can China's competitive disadvantage in vitro diagnostic reagent industry does to promote their survival and development in a highly competitive market.In this paper, KM CO., LTD (KM) is the actual case. Through analyzing the internal and external environment of KM, we obtain the relative importance of various factors impacting strategy of KM's. On this basis, we optimized the enterprise's development strategy and match with the BSC, including the financial strategy, customer / market strategy, internal business processes, innovation and learning strategies. Meanwhile, identify the key success factors and apply it to strategic evaluation of key performance indicators. Further, use these key performance indicators in the implementation of strategic business assessment to analyze the actual results and the differences between the standards set, in order to analyze the aspects that should be improved for KM. Last, we can get the result that the developments of enterprises agree with changes in the market. Through analyzing the status of the KM's strategic management with some analysis tools, we obtained KM's Development Strategy and Implementation. On that basis, we promote the use of in vitro diagnostic reagents, hoping to help numerous small and medium-sized in vitro diagnostic reagents enterprise's strategic management for reference.